These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17396439)

  • 21. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders.
    Fukata J; Shimizu N; Imura H; Hibi I; Tanaka K; Tanaka T; Nakagawa S; Takebe K; Kimura K; Yoshinaga K
    Endocr J; 1993 Oct; 40(5):597-606. PubMed ID: 7951526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Iatrogenic Cushing's syndrome in a infant due to prolonged use of topical corticosteroids. Case report].
    Hansen S J; Lacourt R P
    Rev Chil Pediatr; 2018 Jun; 89(3):368-372. PubMed ID: 29999143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exogenous Cushing syndrome due to misuse of potent topical steroid.
    Özgüç Çömlek F; Örüm S; Aydın S; Tütüncüler F
    Pediatr Dermatol; 2018 Mar; 35(2):e121-e123. PubMed ID: 29315782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are we in danger from an epidemic of Cushing's syndrome? Nature knows its course.
    Weaver JU
    Clin Endocrinol (Oxf); 2001 Dec; 55(6):719-21. PubMed ID: 11895210
    [No Abstract]   [Full Text] [Related]  

  • 25. [Iatrogenic Cushing syndrome due to the misuse of topical corticosteroids. Pediatric case report].
    Edelman S; Buján MM; Cervinia AB
    Arch Argent Pediatr; 2019 Oct; 117(5):e536-e539. PubMed ID: 31560508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis.
    Ellison JA; Patel L; Ray DW; David TJ; Clayton PE
    Pediatrics; 2000 Apr; 105(4 Pt 1):794-9. PubMed ID: 10742322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical steroid-induced Cushing syndrome.
    Al-Khenaizan S; Al Alwan I
    Ann Saudi Med; 2008; 28(4):300-2. PubMed ID: 18596396
    [No Abstract]   [Full Text] [Related]  

  • 28. Cushing's syndrome with adrenal suppression induced by inhaled budesonide due to a ritonavir drug interaction in a woman with HIV infection.
    Yoganathan K; David L; Williams C; Jones K
    Int J STD AIDS; 2012 Jul; 23(7):520-1. PubMed ID: 22844010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cushing's syndrome with suppression of the hypothalamic-pituitary-adrenal axis after intra-articular steroid injections.
    O'Sullivan MM; Rumfeld WR; Jones MK; Williams BD
    Ann Rheum Dis; 1985 Aug; 44(8):561-3. PubMed ID: 4026419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical steroids and hypothalamo-pituitary-adrenal suppression: a review.
    Bartley PC
    Australas J Dermatol; 1978 Dec; 19(3):109-13. PubMed ID: 371599
    [No Abstract]   [Full Text] [Related]  

  • 31. Glucocorticosteroids II: the clinical responses.
    Claman HN
    Hosp Pract (Off Ed); 1983 Jul; 18(7):143-6, 149-51. PubMed ID: 6407967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iatrogenic Cushing's Syndrome Due to Intranasal Usage of Ophthalmic Dexamethasone: A Case Report.
    Orton S; Censani M
    Pediatrics; 2016 May; 137(5):. PubMed ID: 27244810
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iatrogenic Cushing syndrome due to nasal steroid drops.
    Baş VN; Cetinkaya S; Aycan Z
    Eur J Pediatr; 2012 Apr; 171(4):735-6. PubMed ID: 22203429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iatrogenic Cushing's syndrome due to topical steroid abuse in a child with Psoriasis presenting as septicaemia.
    Sachdeva S; Arora P; Kulhari A; Sardana K
    Dermatol Ther; 2020 Jul; 33(4):e13514. PubMed ID: 32374062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of the HPA axis in pediatric patients with atopic dermatitis.
    Ishay A; Ziv M; Kerner M; Luboshitzky R
    Arch Dermatol; 2007 Nov; 143(11):1449-50. PubMed ID: 18025377
    [No Abstract]   [Full Text] [Related]  

  • 36. Endocrine complications of topical and intralesional corticosteroid therapy.
    Curtis JA; Cormode E; Laski B; Toole J; Howard N
    Arch Dis Child; 1982 Mar; 57(3):204-7. PubMed ID: 6462114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cushing's syndrome: hidden risk in usage of topical corticosteroids.
    Buluş AD; Andıran N; Koçak M
    J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):977-81. PubMed ID: 24854522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iatrogenic Cushing's syndrome in children following nasal steroid.
    Oluwayemi IO; Oduwole AO; Oyenusi E; Onyiriuka AN; Abdullahi M; Fakeye-Udeogu OB; Achonwa CJ; Kouyate M
    Pan Afr Med J; 2014; 17():237. PubMed ID: 25170381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iatrogenic hyperadrenocorticism during topical steroid therapy: assessment of systemic effects by metabolic criteria.
    Cook LJ; Freinkel RK; Zugerman C; Levin DL; Radtke R
    J Am Acad Dermatol; 1982 Jun; 6(6):1054-60. PubMed ID: 7047591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature.
    Tempark T; Phatarakijnirund V; Chatproedprai S; Watcharasindhu S; Supornsilchai V; Wananukul S
    Endocrine; 2010 Dec; 38(3):328-34. PubMed ID: 20972726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.